Shift Bioscience
UK - CambridgeBiotechnology
Focus: Shift Bioscience is a UK-based biotech company founded in 2017 specializing in small molecule therapeutics for skin care and anti-aging applications. The company is publicly traded and operates at a modest scale with 17 active job openings.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
17+2 this month
Stable — net +2 jobs in 30d
7 added, 5 removed. Backfill posture.
Should You Work at Shift Bioscience?
AI assessmentShift Bioscience offers early-stage upside in an attractive therapeutic area, but lack of pipeline transparency and R&D hiring raises questions about scientific depth and near-term career development.
Why Work Here
- Public company status provides equity upside potential and transparency into financial health and strategy.
- Niche focus on dermatology/anti-aging represents a growing consumer-adjacent market with commercial momentum.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Shift Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.